Form 4 for PRVA Privia Health Group, Inc.
Accepted 2026-03-12 00:00:00 ET · period of report 2026-03-10 · accession 0001858396-26-000001 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-03-12 | 2026-03-10+ | PRVA | Mountcastle David | EVP, CFO | A - Grant | $0.00 | +77.9K | 239.8K | +48% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.01 per share | 2026-03-10 | A | A | 35,335 | $0.00 | 197,238 | D | — | — | (F1) Reflects restricted stock units under the 2021 Omnibus Incentive Plan that will vest in substantially equal annual installments on the first, second and third anniversaries of the grant date, generally subject to continued service throughout such dates. |
| 2 | Common | Common Stock, par value $0.01 per share | 2026-03-11 | A | A | 42,584 | $0.00 | 239,822 | D | — | — | (F2) Vesting and distribution to reporting person of 42,584 shares underlying performance stock units that were granted on May 9, 2023 for the performance period 2023-2025 . |